Evidence map›Paper›PMID 39744075›Full record

ArticleBJUI compass2024

Investigating the prognostic utility of

Ruth Pidsley, Dilys Lam, Wenjia Qu, Phillip Stricker, James G Kench, Lisa G Horvath, Susan J Clark

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJUI compass, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. GSTP1 inhibits angiotensin II-induced atrial fibrillation by regulating ferroptosis.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ruth PidsleyGarvan Institute of Medical Research Sydney New South Wales Australia.ORCID https://orcid.org/0000-0002-1386-1374
Dilys LamGarvan Institute of Medical Research Sydney New South Wales Australia.
Wenjia QuGarvan Institute of Medical Research Sydney New South Wales Australia.
Phillip StrickerGarvan Institute of Medical Research Sydney New South Wales Australia.ORCID https://orcid.org/0000-0002-0934-0656
James G KenchGarvan Institute of Medical Research Sydney New South Wales Australia.
Lisa G HorvathGarvan Institute of Medical Research Sydney New South Wales Australia.
Susan J ClarkGarvan Institute of Medical Research Sydney New South Wales Australia.ORCID https://orcid.org/0000-0001-5925-5030

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: We aim to determine the prognostic significance of Subjects/Patients and Methods: We first re-examined a published, in-house whole genome bisulphite sequencing (WGBS) prostate cancer dataset, derived from radical prostatectomy (RP) tissue ( Results: Re-analysis of WGBS data showed a significant increase in Conclusion: Our study supports the importance of DNA methylation as a tissue-based prostate tumour biomarker.

Indexed as

biomarkerdiagnosticDNA methylationepigeneticsGSTP1prognosticprostate cancer

Identifiers

PMID39744075
PMCPMC11685177

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.